419 related articles for article (PubMed ID: 16632014)
1. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
[TBL] [Abstract][Full Text] [Related]
2. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
3. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
5. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
6. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
7. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
[TBL] [Abstract][Full Text] [Related]
9. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
[TBL] [Abstract][Full Text] [Related]
10. Thin basement membrane disease in patients with familial IgA nephropathy.
Frascá GM; Soverini L; Gharavi AG; Lifton RP; Canova C; Preda P; Vangelista A; Stefoni S
J Nephrol; 2004; 17(6):778-85. PubMed ID: 15593051
[TBL] [Abstract][Full Text] [Related]
11. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy.
Santos NM; Ault BH; Gharavi AG; Kritchevsky SB; Quasney MW; Jackson EC; Fisher KA; Woodford SY; Mitchell BL; Gaber LW; Arheart KL; Wyatt RJ
Pediatr Nephrol; 2002 Jul; 17(7):496-502. PubMed ID: 12172761
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification of patients with IgA nephropathy.
Barbour SJ; Reich HN
Am J Kidney Dis; 2012 Jun; 59(6):865-73. PubMed ID: 22497792
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and natural history of IgA nephropathy.
Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
[TBL] [Abstract][Full Text] [Related]
16. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
[TBL] [Abstract][Full Text] [Related]
17. IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes.
Haas M; Rahman MH; Cohn RA; Fathallah-Shaykh S; Ansari A; Bartosh SM
Nephrol Dial Transplant; 2008 Aug; 23(8):2537-45. PubMed ID: 18263928
[TBL] [Abstract][Full Text] [Related]
18. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K
Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
[TBL] [Abstract][Full Text] [Related]
19. Influence of cytokine gene polymorphisms on IgA nephropathy.
Bantis C; Heering P; Aker S; Kuhr N; Grabensee B; Ivens K
Ren Fail; 2008; 30(2):135-40. PubMed ID: 18300111
[TBL] [Abstract][Full Text] [Related]
20. The impact of sex in primary glomerulonephritis.
Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]